12:00 AM
 | 
Nov 11, 2013
 |  BC Week In Review  |  Company News  |  Other News

Ariad cancer news

Ariad said it will reduce its U.S. headcount by about 160 (40%) by year end, after which it will have 295 employees in the U.S. and Europe. The move comes after the company temporarily suspended marketing and distribution of leukemia drug ...

Read the full 187 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >